Changes

Jump to navigation Jump to search
moved infobox up
Line 1: Line 1:  +
{{Project Infobox|Self researchers=User:Madprime,User:Sprague |Related tools= |Related topics= }}
 +
 
[[File:Serimmunetypicalresults.png|alt=image of a sample result|thumb|Serimmune antibody test results sample.]]
 
[[File:Serimmunetypicalresults.png|alt=image of a sample result|thumb|Serimmune antibody test results sample.]]
 
The [https://serimmune.com/covid19study/ Serimmune COVID-19 Study] is a longitudinal research study conducted by the Serimmune company. The study uses the company's "Serum Epitope Repertoire Analysis (SERA) technology" to study antibody responses, especially in the context of COVID-19 vaccination and exposure.
 
The [https://serimmune.com/covid19study/ Serimmune COVID-19 Study] is a longitudinal research study conducted by the Serimmune company. The study uses the company's "Serum Epitope Repertoire Analysis (SERA) technology" to study antibody responses, especially in the context of COVID-19 vaccination and exposure.
Line 23: Line 25:     
Serimmune claims their test works very well compared to ELISA. It has a high “specificity” (true negative): when they say a sample doesn’t have COVID, they’re almost always right. In fact, when they applied their test to samples taken before the pandemic, every single time they correctly ruled out COVID.
 
Serimmune claims their test works very well compared to ELISA. It has a high “specificity” (true negative): when they say a sample doesn’t have COVID, they’re almost always right. In fact, when they applied their test to samples taken before the pandemic, every single time they correctly ruled out COVID.
  −
{{Project Infobox|Self researchers=User:Madprime,User:Sprague |Related tools= |Related topics= }}
      
=SARS-CoV-2 Sample Reports =
 
=SARS-CoV-2 Sample Reports =

Navigation menu